i
Loading Page
loading, please wait

Select Year:

Home > TX Providers
provider's profile picture

Dr. Anton M. Melnyk JR., MD, FACP

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology
University of Alberta Faculty of Medicine and Dentistry (1988)
1100 N 19th Street Suite 1a
Abilene, TX 79601

Dr. Anton M. Melnyk JR., MD, FACP is a medical oncologist in Abilene, TX specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Alberta Faculty of Medicine and Dentistry in 1988 and has 37 years of experience. Dr. Anton M. Melnyk JR., MD, FACP is affiliated with Hendrick Health, Texas Oncology, Anton M. Melnyk Jr., MD and Hendrick Medical Center.

View Doctor's Full Profile (325) 672-4368

Office Locations

1100 N 19th Street Suite 1a
Abilene, TX 79601
(325) 672-4368
(325) 672-3108
open_in_new

Texas Oncology

1665 Antilley Road Suite 150
Abilene, TX 79606
(325) 672-4368
open_in_new

Hendrick Medical Center

1904 Pine Street Suite 1a
Abilene, TX 79601
(325) 672-4368
open_in_new
1957 Antilley Road
Abilene, TX 79605
open_in_new

Texas Oncology

1957 Antilley Road
Abilene, TX 79606
(325) 692-0188
open_in_new

In The News 

“"Valentine's Day is the perfect time to show your love and provide a gentle and necessary reminder with a postcard for loved ones to make an appointment for a cancer screening," Dr. Anton Melnyk of...”—"Valentines offer reminder for prostate exams, mammograms", Plainview Herald, July 2016

Noteworthy Medicare Patient Procedures Performed by Dr. Anton M. Melnyk JR., MD, FACP in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

albumin blood test
biological response modifier therapy
chloride blood test
creatinine blood test
intravenous chemotherapy
intravenous infusion
lab tests
total calcium test

By Affordability:

albumin blood test
albumin test
alkaline phosphatase test
ALT test
AST test
bilirubin test
blood differential tests
blood smear
blood urea nitrogen test
calcium blood test
calcium test
carbon dioxide test
chloride blood test
chloride test
therapeutic phlebotomy
total calcium test
total protein blood test
total protein test
white blood cell differential

In 2023, among providers in related specialties within Texas, Dr. Anton M. Melnyk JR., MD, FACP performed more albumin blood test, biological response modifier (BRM) therapy, chloride blood test, creatinine blood test, intravenous (IV) chemotherapy, intravenous (IV) infusion, lab tests, and total calcium test procedures for Medicare patients than 95% of them and he also had a list price for albumin blood test, albumin test, alkaline phosphatase (ALP) test, ALT (SGPT) test, AST (SGOT) test, bilirubin test, blood differential tests, blood smear, blood urea nitrogen (BUN) test, calcium blood test, calcium test, carbon dioxide (CO2) test, chloride blood test, chloride test, therapeutic phlebotomy, total calcium test, total protein blood test, total protein test, and white blood cell (WBC) differential that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Volume:

antineoplastic hormone therapy
blood draw
complete blood count
phlebotomy for lab tests

By Affordability:

abdominal CT scan
cancer antigen tests
carcinoembryonic antigen test
iron tests
lactate dehydrogenase test
liver function tests
magnesium test
neck CT scan
pelvic CT scan
prostate-specific antigen test
total PSA test

In 2023, among providers in related specialties within Texas, Dr. Anton M. Melnyk JR., MD, FACP performed more antineoplastic hormone therapy, blood draw, complete blood count (CBC), and phlebotomy for lab tests procedures for Medicare patients than 90% of them and he also had a list price for abdominal CT scan, cancer antigen tests, carcinoembryonic antigen (CEA) test, iron tests, lactate dehydrogenase (LDH) test, liver function tests (LFTs), magnesium test, neck CT scan, pelvic CT scan, prostate-specific antigen (PSA) test, and total PSA test that was lower than the list prices billed to Medicare by 90% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

abdominal CT scan
chest CT scan
CT scan
inpatient hospital care
pelvic CT scan
port flush
total protein blood test
total PSA test
white blood cell differential

By Affordability:

antineoplastic hormone therapy
blood count tests
chest CT scan
complete blood count
creatinine blood test
creatinine test
CT scan
hormone therapy
kidney function tests
port flush
thoracic imaging

In 2013, among providers in related specialties within Texas, Dr. Anton M. Melnyk JR., MD, FACP performed more abdominal CT scan, chest CT scan, CT scan, inpatient hospital care (for patient admitted to hospital), pelvic CT scan, port flush, total protein blood test, total PSA test, and white blood cell (WBC) differential procedures for Medicare patients than 75% of them and he also had a list price for antineoplastic hormone therapy, blood count tests, chest CT scan, complete blood count (CBC), creatinine blood test, creatinine test, CT scan, hormone therapy, kidney function tests, port flush, and thoracic (chest) imaging that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2013 were lab tests, blood draw, inpatient care and hospital care.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 73
biological response modifier (BRM) therapy 292
blood draw 1673
chemotherapy 292
CT scan 172
doctor visit 1770
hospital care 815
inpatient care 815
lab tests 4626
minimally invasive procedures 333
nursing home care 60
pelvic imaging 73
port flush 28
thoracic (chest) imaging 212
X-rays 113

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 225
Female 346
Ethnicity
Non-Hispanic White 523
Black 0
Hispanic 30
Asian 0
Other 0
Native American 0
Age
From 65 to 74 217
From 75 to 84 244
85 and over 71
Less than 65 39

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2013

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2013 were hypertension, cancer, ischemic heart disease and high cholesterol.

Hypertension 66
High Cholesterol 41
Stroke 4
Ischemic Heart Disease 42
Depression 20
Chronic Kidney Disease 25
Asthma 6
Osteoperosis 8
Atrial Fibrilation 11
Heart Failure 27
Chronic Obstructive Pulmonary Disease 24
Diabetes 29
Dementia 10
Cancer 56

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2014 were lab tests, blood draw, inpatient care and hospital care.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 86
biological response modifier (BRM) therapy 374
blood draw 1704
chemotherapy 374
CT scan 201
doctor visit 1599
hospital care 892
inpatient care 892
lab tests 4695
minimally invasive procedures 346
nursing home care 75
pelvic imaging 86
port flush 53
thoracic (chest) imaging 262
X-rays 147

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 225
Female 360
Ethnicity
Non-Hispanic White 533
Black 0
Hispanic 28
Asian 0
Other 0
Native American 0
Age
From 65 to 74 226
From 75 to 84 241
85 and over 71
Less than 65 47

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2014

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2014 were hypertension, cancer, high cholesterol and ischemic heart disease.

Hypertension 69
High Cholesterol 42
Stroke 3
Ischemic Heart Disease 42
Depression 24
Chronic Kidney Disease 29
Asthma 6
Osteoperosis 10
Atrial Fibrilation 11
Heart Failure 26
Chronic Obstructive Pulmonary Disease 25
Diabetes 30
Dementia 11
Cancer 56

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2015 were lab tests, blood draw, inpatient care and hospital care.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 84
biological response modifier (BRM) therapy 423
blood draw 1687
chemotherapy 423
CT scan 173
doctor visit 1681
hospital care 576
inpatient care 576
lab tests 4514
minimally invasive procedures 390
nursing home care 48
pelvic imaging 84
port flush 46
thoracic (chest) imaging 219
X-rays 130

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 392
Female 738
Ethnicity
Non-Hispanic White 1030
Black 0
Hispanic 56
Asian 0
Other 0
Native American 0
Age
From 65 to 74 446
From 75 to 84 456
85 and over 138
Less than 65 90

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2015

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2015 were hypertension, cancer, high cholesterol and ischemic heart disease.

Hypertension 65
High Cholesterol 45
Stroke 5
Ischemic Heart Disease 41
Depression 22
Chronic Kidney Disease 30
Asthma 15
Osteoperosis 10
Atrial Fibrilation 12
Heart Failure 26
Chronic Obstructive Pulmonary Disease 24
Diabetes 29
Dementia 12
Cancer 55

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2016 were lab tests, blood draw, inpatient care and hospital care.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 83
biological response modifier (BRM) therapy 532
blood draw 1995
chemotherapy 532
CT scan 157
doctor visit 1820
hormone therapy 39
hospital care 546
inpatient care 546
lab tests 5278
minimally invasive procedures 533
pelvic imaging 83
port flush 84
preventive care 11
thoracic (chest) imaging 154
X-rays 80

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 256
Female 410
Ethnicity
Non-Hispanic White 600
Black 0
Hispanic 44
Asian 0
Other 0
Native American 0
Age
From 65 to 74 271
From 75 to 84 267
85 and over 73
Less than 65 55

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2016

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2016 were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension 73
High Cholesterol 52
Stroke 3
Ischemic Heart Disease 44
Depression 24
Chronic Kidney Disease 33
Asthma 26
Osteoperosis 11
Atrial Fibrilation 12
Heart Failure 29
Chronic Obstructive Pulmonary Disease 23
Diabetes 32
Dementia 12
Cancer 50

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2017 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 61
biological response modifier (BRM) therapy 482
blood draw 1957
chemotherapy 482
CT scan 129
doctor visit 1808
hormone therapy 35
hospital care 404
inpatient care 404
lab tests 5582
minimally invasive procedures 547
pelvic imaging 61
port flush 86
thoracic (chest) imaging 164
X-rays 96

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 269
Female 434
Ethnicity
Non-Hispanic White 629
Black 0
Hispanic 49
Asian 0
Other 0
Native American 0
Age
From 65 to 74 294
From 75 to 84 283
85 and over 82
Less than 65 44

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2017

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2017 were hypertension, cancer, ischemic heart disease and high cholesterol.

Hypertension 74
High Cholesterol 44
Stroke 5
Ischemic Heart Disease 45
Depression 21
Chronic Kidney Disease 40
Asthma 7
Osteoperosis 11
Atrial Fibrilation 12
Heart Failure 26
Chronic Obstructive Pulmonary Disease 21
Diabetes 32
Dementia 13
Cancer 51

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 104
biological response modifier (BRM) therapy 430
blood draw 1759
chemotherapy 430
CT scan 211
doctor visit 1648
hormone therapy 41
hospital care 283
inpatient care 283
lab tests 5473
minimally invasive procedures 521
pelvic imaging 104
port flush 91
thoracic (chest) imaging 107

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 262
Female 415
Ethnicity
Non-Hispanic White 602
Black 0
Hispanic 47
Asian 0
Other 0
Native American 0
Age
From 65 to 74 284
From 75 to 84 262
85 and over 80
Less than 65 51

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2018

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2018 were hypertension, cancer, high cholesterol and ischemic heart disease.

Hypertension 72
High Cholesterol 51
Stroke 4
Ischemic Heart Disease 43
Depression 22
Chronic Kidney Disease 37
Asthma 6
Osteoperosis 10
Atrial Fibrilation 11
Heart Failure 25
Chronic Obstructive Pulmonary Disease 23
Diabetes 31
Dementia 11
Cancer 53

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 53
biological response modifier (BRM) therapy 306
blood draw 1352
chemotherapy 306
CT scan 137
doctor visit 1436
hormone therapy 59
hospital care 278
inpatient care 278
lab tests 4286
minimally invasive procedures 432
pelvic imaging 53
port flush 88
thoracic (chest) imaging 84

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 284
Female 402
Ethnicity
Non-Hispanic White 608
Black 0
Hispanic 46
Asian 0
Other 0
Native American 0
Age
From 65 to 74 287
From 75 to 84 264
85 and over 93
Less than 65 42

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2019

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2019 were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension 75
High Cholesterol 58
Stroke 6
Ischemic Heart Disease 44
Depression 26
Chronic Kidney Disease 44
Asthma 6
Osteoperosis 13
Atrial Fibrilation 10
Heart Failure 24
Chronic Obstructive Pulmonary Disease 25
Diabetes 34
Dementia 14
Cancer 53

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 60
biological response modifier (BRM) therapy 527
blood draw 1381
chemotherapy 527
CT scan 141
doctor visit 1432
hormone therapy 51
hospital care 264
inpatient care 264
lab tests 4220
minimally invasive procedures 593
pelvic imaging 60
port flush 71
thoracic (chest) imaging 81

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 260
Female 393
Ethnicity
Non-Hispanic White 580
Black 0
Hispanic 44
Asian 0
Other 0
Native American 0
Age
From 65 to 74 275
From 75 to 84 239
85 and over 96
Less than 65 43

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2020

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2020 were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension 71
High Cholesterol 53
Stroke 5
Ischemic Heart Disease 43
Depression 23
Chronic Kidney Disease 41
Asthma 5
Osteoperosis 13
Atrial Fibrilation 13
Heart Failure 25
Chronic Obstructive Pulmonary Disease 21
Diabetes 32
Dementia 14
Cancer 51

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 118
biological response modifier (BRM) therapy 590
blood draw 1719
chemotherapy 590
CT scan 256
doctor visit 1759
hormone therapy 56
hospital care 275
inpatient care 275
lab tests 4716
minimally invasive procedures 672
pelvic imaging 118
port flush 111
radiation therapy 43
thoracic (chest) imaging 138

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 307
Female 447
Ethnicity
Non-Hispanic White 678
Black 20
Hispanic 44
Asian 0
Other 0
Native American 0
Age
From 65 to 74 326
From 75 to 84 285
85 and over 101
Less than 65 42

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2021

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2021 were hypertension, cancer, high cholesterol and ischemic heart disease.

Hypertension 71
High Cholesterol 51
Stroke 4
Ischemic Heart Disease 40
Depression 21
Chronic Kidney Disease 36
Asthma 6
Osteoperosis 10
Atrial Fibrilation 13
Heart Failure 23
Chronic Obstructive Pulmonary Disease 19
Diabetes 31
Dementia 14
Cancer 52

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 135
biological response modifier (BRM) therapy 676
blood draw 1621
chemotherapy 676
CT scan 266
doctor visit 1727
hormone therapy 90
hospital care 416
inpatient care 416
lab tests 6991
minimally invasive procedures 831
pelvic imaging 135
port flush 125
thoracic (chest) imaging 131

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 311
Female 459
Ethnicity
Non-Hispanic White 690
Black 24
Hispanic 38
Asian 0
Other 0
Native American 0
Age
From 65 to 74 347
From 75 to 84 285
85 and over 102
Less than 65 36

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2022

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2022 were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension 75
High Cholesterol 68
Stroke 8
Ischemic Heart Disease 34
Depression 24
Chronic Kidney Disease 24
Asthma 8
Osteoperosis 16
Atrial Fibrilation 22
Heart Failure 21
Chronic Obstructive Pulmonary Disease 24
Diabetes 32
Dementia 7
Cancer 58

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

The top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX during 2023 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

abdominal imaging 105
biological response modifier (BRM) therapy 567
blood draw 1443
chemotherapy 567
CT scan 238
doctor visit 1642
hormone therapy 111
hospital care 247
inpatient care 247
lab tests 6416
minimally invasive procedures 849
neck imaging 12
pelvic imaging 105
port flush 78
thoracic (chest) imaging 121

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 310
Female 463
Ethnicity
Non-Hispanic White 698
Black 22
Hispanic 38
Asian 0
Other 0
Native American 0
Age
From 65 to 74 348
From 75 to 84 288
85 and over 105
Less than 65 32

Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP in 2023

The most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated during 2023 were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension 75
High Cholesterol 72
Stroke 8
Ischemic Heart Disease 34
Depression 22
Chronic Kidney Disease 26
Asthma 8
Osteoperosis 16
Atrial Fibrilation 24
Heart Failure 19
Chronic Obstructive Pulmonary Disease 23
Diabetes 32
Dementia 7
Cancer 55

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2013 - 2023

Volume of procedures performed by Dr. Anton M. Melnyk JR., MD, FACP for Medicare patients.

The highest averages for the top procedures that Dr. Anton M. Melnyk JR., MD, FACP treated as a medical oncologist in Abilene, TX were lab tests, blood draw, minimally invasive procedures and chemotherapy.

abdominal imaging 87
biological response modifier (BRM) therapy 472
blood draw 1662
chemotherapy 472
CT scan 189
doctor visit 1665
hormone therapy 60
hospital care 454
inpatient care 454
lab tests 5163
minimally invasive procedures 549
neck imaging 12
nursing home care 61
pelvic imaging 87
preventive care 11
radiation therapy 43
thoracic (chest) imaging 152
X-rays 113

Average Medicare Patient Data From 2013 - 2023

Information about Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP.

Gender
Male 281
Female 442
Ethnicity
Black / African American 6
Asian / Pacific Islander 0
Non-Hispanic White 651
Native American / Alaskan Native 0
Hispanic 42
Other 0
Age
75 to 84 283
85 and over 92
Less than 65 47
65 to 74 301

Average of Total of Conditions of Medicare patients treated by Dr. Anton M. Melnyk JR., MD, FACP From 2013 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Anton M. Melnyk JR., MD, FACP treated were hypertension, cancer, high cholesterol and ischemic heart disease.

Hypertension 71
High Cholesterol 52
Stroke 5
Ischemic Heart Disease 41
Depression 22
Chronic Kidney Disease 33
Asthma 9
Osteoporosis 11
Heart Failure 24
Chronic Obstructive Pulmonary Disease 22
Diabetes 31
Atrial Fibrillation 13
Cancer 53
Dementia 11

Education & Training

Dr. Anton M. Melnyk JR., MD, FACP graduated from University of Alberta Faculty of Medicine and Dentistry in 1988. He completed residency at University of Alberta Affiliated Hospitals. He is certified by the Hematology Internal Medicine Medical Oncology and has a state license in Texas.

Medical School: University of Alberta Faculty of Medicine and Dentistry (1988)

Residency: University of Alberta Affiliated Hospitals (1993)

Board Certification: Hematology Internal Medicine Medical Oncology

Licensed In: Texas

Affiliations & Hospitals

Dr. Anton M. Melnyk JR., MD, FACP is associated with these hospitals and organizations:

Hendrick Health
Texas Oncology
Anton M. Melnyk Jr., MD
Hendrick Medical Center

Ratings & Reviews

Dr. Anton M. Melnyk JR., MD, FACP does not have any reviews yet, be the first to leave a review of Dr. Anton M. Melnyk JR., MD, FACP here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Anton M. Melnyk JR., MD, FACP. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Payments by Company
Lilly USA, LLC $7,587 JAYPIRCA
$99
$7,488
Gilead Sciences, Inc. $3,761 Trodelvy
$3,678 		Zydelig
$71
$12
TESARO, Inc. $3,592 ZEJULA
$3,592
CTI BioPharma Corp. $1,833 Vonjo
$1,833
F. Hoffmann-La Roche AG $1,818 Non-Covered Product
$1,818
Other $12,111 BRUKINSA
$1,350 		INLYTA
$1,157 		Aranesp
$1,035 		KEYTRUDA
$423 		IMBRUVICA
$409 		Other
$7,737
Types of Payments
Consulting Fee $18,688
Food and Beverage $7,920
Honoraria $1,725
Travel and Lodging $1,713
Education $624
Other $31

Research Payments

Dr. Anton M. Melnyk JR., MD, FACP has received 546 research payments totaling $1,359,400.

Biography

Dr. Anton Melnyk's medical specialty is adult hematology, adult oncology, and medical oncology. His professional affiliations include Hendrick Health and Texas Oncology. He is a graduate of the University of Alberta Faculty of Medicine and Dentistry. Dr. Melnyk's training includes a residency program at a hospital affiliated with the University of Alberta.

Other Providers in Abilene, TX